BAL Lazio

HTA

HTA – Documenti

Pubblicato lunedì 5 Maggio 2014

ITALIA

Ricciardi W, Agostinelli A, La Torre G, Cicchetti A, Derrico P, Paternello F, ViHTA Project Team. Primo Libro Bianco sull’Health Technology Assessment in Italia. (PDF 2499 KB) Progetto ViHTA. Valore in Health Technology Assessment 2010. Istituto d’Igiene, Università Cattolica del Sacro Cuore.

Ministero della salute. Direzione generale dei medicinali e dei dispositivi medici. Dispositivi medici. Aspetti regolatori e operativi, II edizione, Roma 2010.

Ministero della Salute: Sicurezza dei pazienti e gestione del rischio clinico: Manuale per la formazione degli operatori sanitari (PDF 742 KB), 2007.

Agenas
I report HTA a cura dell’age.na.s.
Supporto per gli acquisti di tecnologie sanitarie e monitoraggio prezzi, 2012. Accordo di collaborazione Regione Friuli Venezia Giulia – Direzione centrale salute integrazione sociosanitaria e politiche sociali. Agenas – Agenzia nazionale per i servizi sanitari regionali.

RESTO DEL MONDO
Goodman CS. HTA 101: Introduction to Health Technology Assessment. National Library of Medicine.The Lewin Group Falls Church, Virginia, USA, 2004.

Murphy E, Dingwall R, Greatbatch D, Parker S, Watson P. Qualitative research methods in health technology assessment: a review of the literature. Health Technol Assess 1998; 2: 1-274.

NICE – National Institute for Health and Clinical Excellence. A guide for patient/carer groups – Contributing to a technology appraisal (PDF, 114 KB), 2004.

Topfer LA, Auston I. E-text on Health Technology Assessment (HTA) information resources. National Information Centre on Health Services Research and Health Care Technology (NICHSR), 2003. First published: 01 January 2002 Last updated: 18 May 2004 Date Archived: 05 September 2006.

Velasco Garrido M, Borlum Kristiensen F, Palmhoj Nielsen C, Busse R, eds. Health technology assessment and health policy making in Europe. (PDF, 1239 KB) Copenhagen: European Observatory-WHO, 2008.

Archiviato in ,

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Accedi agli articoli

Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet 2019;394(10204):1159-68.

Vinogradova Y et al. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ 2020; 371 :m3873

Gibbison B al. Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass. Cochrane Database of Systematic Reviews 2020, Issue 10.

Hartmann‐Boyce  J, McRobbie  H, Bullen  C, Begh  R, Stead  LF, Hajek  P. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews 2016, Issue 9. Art. No.: CD010216. DOI:

Miovský M et al. Attention Deficit Hyperactivity Disorder among clients diagnosed with a substance use disorder in the therapeutic communities: prevalence and psychiatric comorbidity. Eur Addict Res 2020.

Ortel TL et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 2020; 4(19): 4693-4738.

Chu JJ et al. Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial. Lancet 2020 Sep 12;396(10253):770-778.

Vodicka TA et al. Reducing antibiotic prescribing for children with respiratory tract infections in primary care: a systematic review. Br J Gen Pract 2013;63(612):e445-54.

Dominici F, et al. Air pollution, SARS-CoV-2 transmission, and COVID-19 outcomes: a state-of-the-science review of a rapidly evolving research area. medRxiv 2020. doi: https://doi.org/10.1101/2020.08.16.20175901

Marion M Mafham et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet 2020;S0140-6736(20)31356-8.

Orkaby AR. Association of statin use with all-cause and cardiovascular mortality in US veterans 75 years and older. JAMA 2020;324(1):68-78

Una finestra sull’open access

  • BMC Family Practice
  • BMC Medical Education
  • BMC Nursing
  • BMJ Open
  • PLOS Medicine

Reset della password

Per favore inserisci la tua email. Riceverai una nuova password via email.